Invesaro

Stocks Health care CBDL

OTC · Health care

CBD Life Sciences Inc. (CBDL)

We have not processed filings for CBD Life Sciences Inc. yet. This page fills in on its own once we have read them.

Watch CBDL in 60 seconds
Price
$0.00
0.00% on the day · September 25, 2026
52-week range $0.00 to $0.00

What CBD Life Sciences Inc. does

CBD Life Sciences Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker CBDL.

Latest SEC filings

What CBD Life Sciences Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. June 8, 2026
  2. May 15, 2026
  3. May 19, 2025
  4. March 19, 2025
  5. March 17, 2025
  6. March 6, 2025
  7. January 22, 2025
  8. September 19, 2024
  9. September 17, 2024
  10. September 6, 2024

All filings on SEC EDGAR

Questions about CBDL

What does CBD Life Sciences Inc. do?

CBD Life Sciences Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker CBDL.

When did CBD Life Sciences Inc. last report?

Its newest filing of any kind is the form QUALIF filing from June 8, 2026.

Similar companies

Compare CBDL with

Compare CBDL with any company

Follow CBDL

Get an email when CBD Life Sciences Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow CBDL: get an email when it files

Where the numbers come from

Financial figures are the values CBD Life Sciences Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.